Medicofarma Biotech SA (INB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

INTERSPORT Polska SA

Polaris IT Group SA

Medicofarma Biotech SA

Present24 SA

Why is Medicofarma Biotech SA ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Medicofarma Biotech SA for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Medicofarma Biotech SA

25.31%

-0.21

175.33%

Poland WIG

39.24%

1.84

20.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-39.73%

EBIT Growth (5y)

-208.01%

EBIT to Interest (avg)

-1.63

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.11

Tax Ratio

0.75%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

EV to EBITDA

EV to Capital Employed

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-54.58%

ROE (Latest)

-58.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bearish

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET PROFIT(HY)

Higher at PLN -1.38 MM

RAW MATERIAL COST(Y)

Fallen by -99.63% (YoY

-27What is not working for the Company

NET SALES(HY)

At PLN 0.11 MM has Grown at -89.41%

INTEREST(HY)

At PLN 0 MM has Grown at 428.92%

OPERATING CASH FLOW(Y)

Lowest at PLN -1.52 MM

ROCE(HY)

Lowest at -45.19%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.56%

PRE-TAX PROFIT(Q)

Fallen at -45.96%

NET PROFIT(Q)

Fallen at -45.96%

Here's what is working for Medicofarma Biotech SA

Raw Material Cost

Fallen by -99.63% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medicofarma Biotech SA

Net Sales

At PLN 0.11 MM has Grown at -89.41%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (PLN MM)

Interest

At PLN 0 MM has Grown at 428.92%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (PLN MM)

Operating Cash Flow

Lowest at PLN -1.52 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (PLN MM)

Pre-Tax Profit

Fallen at -45.96%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (PLN MM)

Net Profit

Fallen at -45.96%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (PLN MM)

Debtors Turnover Ratio

Lowest at 0.56%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio